Objective: This study was performed to investigate whether diffusion-weighted imaging (DWI) and susceptibility-weighted imaging (SWI) are more effective than conventional imaging modalities for evaluation of stroke and selection of candidates for thrombolytic therapy. Methods: Eighty patients who presented within 12 hours of onset of symptoms of brain ischemia underwent 1.5T magnetic resonance imaging. DWI and SWI were compared with conventional sequences (T1, T2, and fluid-attenuated inversion recovery [FLAIR]) and time-of-flight magnetic resonance angiography (TOF-MRA) to assess factors that affect stroke management and prognosis. Results: The volume of brain tissue showing hyperintensity was significantly greater than that showing diffusion restriction in patients with a >6-hour symptom onset. The hypointensity sign
Introduction
Advances in magnetic resonance imaging (MRI) neuroimaging have exponentially increased with the advent of stronger magnet systems and biomedical technology during the past two decades, leading to early detection and treatment of stroke. Stroke is emerging as a leading cause of mortality and morbidity. With the advent of newer imaging techniques such as diffusion-weighted imaging (DWI) and susceptibility-weighted imaging (SWI), management of stroke is moving toward imaging-based approaches rather than by strict time criteria. Studies have shown good results of the use of imaging criteria to select patients for thrombolytic therapy. 1 The onset of stroke symptoms is conventionally defined as the time since the patient was last known to be asymptomatic. Using this definition, many patients whose onset of symptoms was not witnessed (e.g., during sleep) would be ineligible for therapy despite the fact that their time of onset falls within the standard time criteria. 2 DWI can demonstrate cytotoxic edema as early as 10 minutes after onset and is more conspicuous than conventional sequences. 3 DWI uses the principle of ischemia-induced restriction of water movement within the intracellular and extracellular compartments. These ischemic areas appear bright on DWI and dark on apparent diffusion coefficient (ADC) maps. 4 DWI has a low false-negative rate of approximately 5%. 5 SWI takes advantage of local field inhomogeneities and the susceptibility effects of different components to produce contrast between the tissues. Deoxyhemoglobin is paramagnetic because of the presence of unpaired electrons. This causes inhomogeneity in the magnetic field and rapid dephasing of proton spins in SWI sequences. 6 In addition to the obvious hemorrhage that is depicted on computed tomography (CT) and conventional magnetic resonance imaging (MRI) sequences, SWI can detect micro-hemorrhages, the presence of which is associated with a higher risk of postthrombolytic hemorrhagic transformation. 6, 7 SWI can detect spontaneous and post-thrombolytic hemorrhagic transformation earlier than CT. 8 Various factors are reportedly associated with a poor prognosis of ischemic stroke and its therapy. Apart from direct neuronal loss, most of these factors involve loss of integrity of the vascular walls because of ischemia, which causes vasogenic edema and hemorrhagic transformation. Many patients in whom the time of symptom onset is unclear are encountered in clinical practice. In such patients, FLAIR-DWI mismatch can be used to assess the time of onset. In this study, fluid-attenuated inversion recovery (FLAIR)-DWI mismatch has been used to determine the possible time of symptom onset. Factors such as cortical venous congestion, micro-hemorrhagic foci, and SWI-DWI mismatch have been investigated as possible markers of loss of vascular integrity and thus contraindications for thrombolysis and markers of an unfavorable prognosis. This research was undertaken to study the role of advanced imaging sequences in patients with stroke and various factors that can guide institution of therapy and warn against poor prognostic factors that may portend a poor outcome following therapy.
Materials and methods
An analytical study was performed for a period of 3 years in a tertiary care hospital. The study involved patients who presented within 12 hours of onset of symptoms of brain ischemia and were advised to undergo MRI for further evaluation.
Patients with contraindications for MRI, such as the presence of intracranial aneurysm clips and cochlear implants, were excluded. Patients in whom imaging was suboptimal due to motion artifacts were also excluded. Written informed consent was obtained from the patients whenever feasible; family members provided consent for patients who were too incapacitated to provide proper consent. Approval was obtained from the institutional scientific and ethics committee before initiation of the study. Non-contrast brain MRI was performed using an 18-channel (head coil) 1.5T MRI scanner (Avanto; Siemens, Erlangen, Germany). Conventional sequences (T1, T2, and FLAIR), DWI, ADC maps, SWI (phase, minimum-intensity projections, magnitude projections, and combined images), and time-of-flight (TOF) magnetic resonance angiography (MRA) were acquired in all patients. The DWI, ADC, and SWI findings were noted and measurements acquired. A radiologist with >10 years of experience analyzed the images, which were read primarily by the senior resident. The parameters assessed were the volume of brain tissue showing hyperintensity on FLAIR, the volume of brain tissue showing diffusion restriction, susceptibility-diffusion mismatch, a hypointensity sign on SWI with corresponding abnormality on TOF-MRA, the presence of hemorrhagic foci, venous congestion on SWI, and correlations of these parameters with the time of symptom onset. The volume of brain tissue was measured using software on the Advantage Workstation for Windows (GE Healthcare, Chicago, IL, USA). Venous congestion was visually assessed by the radiologist. Patients who underwent intravenous thrombolysis were followed up for hemorrhagic transformation or clinical improvement. The results were analyzed by the chi-square test, regression analysis, and receiver operating characteristic (ROC) analysis using SPSS version 14.0 (SPSS Inc., Chicago, IL, USA).
Results
Eighty patients who presented within 12 hours of onset of symptoms of brain ischemia were evaluated. Of these 80 patients, 42 (52.5%) presented within 6 hours of symptom onset and 38 (47.5%) presented at or after 6 hours of symptom onset. The patients ranged in age from 12 to 85 years; 24 (30%) were aged >70 years, 44 (55%) were aged 50 to 70 years, and 12 (15%) were aged <50 years.
The infarcted volume of brain tissue ranged from 6 to 88 mL as measured on FLAIR sequences. Figures 1-3) . The hypointensity sign on SWI was highly correlated with abnormal findings on TOF-MRA (p ¼ 0.001) (Figure 3 ). Diffusion-susceptibility mismatch was seen in 16 (20.0%) of the 80 patients (Figures 2, 4 , and 5). Diffusion-susceptibility mismatch was not correlated with the volume of infarcted brain tissue or time since onset of symptoms. Micro-hemorrhagic foci on SWI ( Figure 6 ) were seen in 28 of the 80 patients (35.0%). ROC analysis showed associated microhemorrhagic foci in infarcts with a cut-off volume of 27 mL on DWI (sensitivity, 71.4%; specificity, 85.0%). Cortical venous congestion was seen in 16 (20.0%) patients. No statistically significant correlation was found between cortical venous congestion and either the volume of brain tissue showing diffusion restriction or the time since onset of symptoms. However, thrombolysis resulted in resolution of cortical venous congestion. Of the 80 patients, 24 underwent intravenous thrombolysis. Post-thrombolysis hemorrhagic transformation occurred in six patients. Early spontaneous hemorrhagic transformation was seen in four patients and was depicted by SWI. T1/T2/FLAIR failed to demonstrate the hemorrhagic transformation. SWI-DWI mismatch was observed in 16 of the 80 patients (Figures 6  and 7 ). Of these 16 patients, 10 underwent thrombolysis, and all of them showed improvement of muscle power by 3 grades. In the 14 other patients who did not demonstrate diffusion-susceptibility mismatch, the improvement in muscle power ranged from 1 to 3 grades. Clinical assessment was performed 6 hours after instituting therapy. 
Discussion
SWI and DWI play an important role in imaging of patients with acute stroke. Several DWI and SWI features were examined in the present study of 80 patients with acute ischemic stroke.
Among the 80 patients who presented with stroke, the volume of brain tissue showing hyperintensity on FLAIR was greater than the volume of brain tissue showing diffusion restriction in patients with a symptom onset of >6 hours (p ¼ 0.001). The volume of brain tissue showing hyperintensity increased with time in this study, and this is consistent with the findings reported by other investigators. 9 Using our formula for calculation of the time of onset based on DWI-FLAIR mismatch, thrombolysis can be offered to patients with an unknown time of symptom onset who would otherwise not receive thrombolysis if strict time criteria were followed.
The hypointense vessel sign on SWI is caused by a high concentration of deoxyhemoglobin and clot retraction in the thrombosed vessel. Deoxyhemoglobin is a paramagnetic substance that produces a blooming artifact on SWI.
10 At 1.5T, the T2 relaxation time of arterial blood is higher than that of venous blood (approximately 200 vs. 100 ms, respectively).
11
In the present study, 48 of the 80 patients (60.0%) showed TOF-MRA abnormalities indicating occlusion of the vessels. Of these 48 patients, the hypointensity sign on SWI was present in 44 patients. The hypointense vessel sign showed a sensitivity of 66.7%, specificity of 87.5%, positive predictive value of 88.9, and negative predictive value of 63.6 for intracranial arterial occlusions. The hypointensity sign on SWI was significantly correlated with intracranial arterial occlusions on TOF-MRA (p ¼ 0.001). In another study, a strong correlation was found between the location of the thrombus on SWI and that on TOF-MRA (Pearson's correlation coefficient ¼ 0.918, p < 0.001), 12 which is comparable with our study.
Another study showed a sensitivity of 82% and specificity of 100% of the susceptibility sign for acute intracranial arterial occlusions. 13 Our sensitivity and specificity for this sign were lower. However, the aforementioned study used contrastenhanced MRA as the gold standard instead of TOF-MRA. Not all acute thrombi produce blooming. The changes in the paramagnetic effect of the thrombus compared with the rest of the flowing blood depend on the content of the clot. Clots in which white blood cells predominate show more subtle changes in the paramagnetic effect than do clots in which red blood cells predominate.
14 Micro-hemorrhagic foci on SWI were seen in 28 of the 80 patients (35.0%) in the present study. Micro-hemorrhagic foci were significantly correlated with a time since symptom onset of >6 hours (p ¼ 0.026). Micro-hemorrhagic foci were also significantly associated with the volume of infarcted brain tissue showing diffusion restriction (p ¼ 0.007). ROC analysis showed an association between microhemorrhagic foci and infarcts with a cut-off volume of 27 mL on DWI (sensitivity, 71.4%; specificity, 85.0%). Anticoagulant use per se should not cause intracerebral hemorrhage if the cerebral vessels are intact and therapeutic doses are adhered to. However, the presence of microangiopathy causes small vessels to become fragile. This could act as an aggravating factor for post-thrombolysis intracranial hemorrhage. 15 The significant association of micro-hemorrhagic foci with a time of symptom onset of >6 hours could be explained by vasculopathy induced by prolonged ischemia. This is further supported by the association between microhemorrhage and larger-volume of infarcts found in our study. More severe ischemia induces a greater increase in the fragility of small vessels. However, the literature shows conflicting results regarding the association of micro-hemorrhages with postthrombolysis intracranial hemorrhage. A study performed by Gratz et al. 16 showed no significant correlation between the presence of micro-hemorrhages and post-thrombolytic intracranial hemorrhage. In contrast, a study performed by Soo et al. 17 showed that the presence of more than five microbleeds was associated with a higher risk of post-thrombolytic intracranial hemorrhage.
Venous congestion was detected in 16 (20.0%) of all 80 patients. Venous congestion was not detected in any other sequence (T1, T2, FLAIR), thus making it 100% sensitive. The thin imaging sections used in SWI and the high sensitivity of SWI to deoxyhemoglobin products are responsible for the detection of venous congestion. 18 No statistically significant correlation was found between cortical venous congestion and either the volume of brain tissue showing diffusion restriction or the time since onset of symptoms in our study. This implies that venous congestion does not depend on the clot burden. SWI-DWI mismatch was found in 16 of the 80 patients. Of these 16 patients, 10 underwent thrombolysis and all showed improvement of muscle power by 3 grades. In the 14 other patients who did not demonstrate diffusion-susceptibility mismatch, the improvement in muscle power ranged from 1 to 3 grades. There is evidence to suggest a more favorable post-thrombolysis outcome in patients with diffusion-susceptibility mismatch than in patients who do not demonstrate this sign. 18 The main limitation of our study was the relatively small sample size. However, the novelty of this study is the comparison of DWI and MRA with susceptibility sequences. We did not take into account the role of CT or the Alberta Stroke Program Early CT Score (ASPECTS) scoring system. DWI and SWI should be part of the routine imaging protocol for patients with acute stroke and should be used as a decision-making tool to select patients for thrombolytic therapy.
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